Skip to main content

FDA awards Castle Creek $1.8M grant for late-stage testing of gene therapy for 'butterfly children'

The company's gene therapy is being developed to treat a rare disease that causes skin to easily blister from any type of friction.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.